Skip to main content

Table 3 Factors that were found to affect the long-term prognosis in IgAN patients receiving glucocorticoid medicine therapy in the multivariate COX regression analyses

From: Long-term kidney survival analyses in IgA nephropathy patients under steroids therapy: a case control study

Characteristics

Univariate analysis

Multivariate analysis

HR

95% CI

P value

HR

95% CI

P value

Model 1 (n = 200)

 Age (years)

1.063

1.014–1.115

0.011

  

0.20

 Gender

  

0.48

  

0.42

 TA-eGFR (mL/min/1.73 m2)

0.978

0.957–1.000

0.048

0.971

0.945–0.998

0.03

 TA-ALB (g/L)

0.778

0.663–0.913

0.002

0.772

0.636–0.937

0.008

 UPE at month 3 (g/day)

1.000

1.000–1.001

0.016

  

0.40

Model 2 (n = 200)

 Age (years)

1.063

1.014–1.115

0.011

  

0.25

 Gender

  

0.48

  

0.32

 Non-remission (vs remission)

5.877

2.031–17.006

0.001

4.995

1.436–17.365

0.011

 TA-eGFR (mL/min/1.73 m2)

0.978

0.957–1.000

0.048

0.962

0.933–0.992

0.013

 TA-ALB (g/L)

0.778

0.663–0.913

0.002

0.806

0.673–0.966

0.019

 UPE at month 3 (g/day)

1.000

1.000–1.001

0.016

  

0.99

Model 3 (n = 160)

 Age (years)

1.063

1.014–1.115

0.011

  

0.52

 Gender

  

0.48

  

0.13

 Relapse (vs non-relapse)

12.602

1.443–110.058

0.022

12.629

1.446–110.32

0.021

 TA-eGFR (mL/min/1.73 m2)

0.978

0.957–1.000

0.048

  

0.06

 TA-ALB (g/L)

0.778

0.663–0.913

0.002

  

0. 12

 UPE at month 3 (g/day)

1.000

1.000–1.001

0.016

  

0.28